Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro

Journal of Cellular Biochemistry

Volumn 93, Issue 5, 2004, Pages 896-903

  Aitken, Cathy J ^a   Hodge, Jason M ^a   Nicholson, Geoffrey C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adenoviral gene transfer; Osteoclast differentiation; Osteopontin

Indexed keywords

ADENOVIRUS VECTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; ANTISENSE OLIGONUCLEOTIDE; CARRIER PROTEIN; MEMBRANE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN; SPP1 PROTEIN, MOUSE; TNFRSF11A PROTEIN, HUMAN; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, HUMAN; TNFSF11 PROTEIN, MOUSE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENTIN; DOWN REGULATION; HUMAN; IN VITRO STUDY; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; ADENOVIRUS; ANIMAL; CELL CULTURE; CYTOLOGY; GENE TRANSFER; GENE VECTOR; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ADENOVIRIDAE; ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; OLIGONUCLEOTIDES, ANTISENSE; OSTEOCLASTS; OSTEOPONTIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIALOGLYCOPROTEINS;

EID: 28744438600     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20247     Document Type: Article

References (33)

1. Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, Denhardt DT, Noda M. 2001. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142:1325-1332.
2. Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M. 2002. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J Biol Chem 277:21971-21982.
3. Carron CP, Meyer DM, Engleman VW, Rico JG, Ruminski PG, Ornberg RL, Westlin WF, Nickols GA. 2000. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone. J Endocrinol 165:587-598.
4. Chatterjee S, Li W, Wong CA, Fisher-Adams G, Lu D, Guha M, Macer JA, Forman SJ, Wong KK, Jr. 1999. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 93:1882-1894.
5. Chellaiah MA, Hruska KA. 2003. The integrin alpha(v)-beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 72:197-205.
6. Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA. 2003. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 14:173-189.
7. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. 2001. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055-1061.
8. Duong LT, Nakamura I, Lakkakorpi PT, Lipfert L, Bett AJ, Rodan GA. 2001. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. J Biol Chem 276:7484-7492.
9. Engleman VW, Nickols GA, Ross FP, Horton MA, Griggs DW, Settle SL, Ruminski PG, Teitelbaum SL. 1997. A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest 99:2284-2292.
10. Flores ME, Norgard M, Heinegard D, Reinholt FP, Andersson G. 1992. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Exp Cell Res 201:526-530.
11. Gravallese EM. 2003. Osteopontin: A bridge between bone and the immune system. J Clin Invest 112:147-149.
12. Hodge JM, Kirkland MA, Aitken CJ, Waugh CM, Myers DE, Lopez CM, Adams BE, Nicholson GC. 2004. Osteoclastic potential of human CFU-GM: Biphasic effect of GM-CSF. J Bone Miner Res 19:190-199.
13. Hruska KA, Rolnick F, Huskey M, Alvarez U, Cheresh D. 1995. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology 136:2984-2992.
14. Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, Hruska KA, Higashio K, Enomoto S, Nifuji A, Rittling SR, Noda M. 2001. Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem 276:13065-13071.
15. Ikeda T, Nomura S, Yamaguchi A, Suda T, Yoshiki S. 1992. In situ hybridization of bone matrix proteins in unde-calcified adult rat bone sections. J Histochem Cytochem 40:1079-1088.
16. Kania JR, Kehat-Stadler T, Kupfer SR. 1997. CD44 antibodies inhibit osteoclast formation. J Bone Miner Res 12:1155-1164.
17. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T. 1999. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59:219-226.
18. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. 1998. Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 101:1468-1478.
19. Moore MA, Gotoh Y, Rafidi K, Gerstenfeld LC. 1991. Characterization of a cDNA for chicken osteopontin: Expression during bone development, osteoblast differentiation, and tissue distribution. Biochemistry 30:2501-2508.
20. Nakamura I, Pilkington MF, Lakkakorpi PT, Lipfert L, Sims SM, Dixon SJ, Rodan GA, Duong LT. 1999. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone. J Cell Sci 112:3985-3993.
21. Oldberg A, Franzen A, Heinegard D. 1986. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83:8819-8823.
22. Prince CW, Dickie D, Krumdieck CL. 1991. Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun 177:1205-1210.
23. Reinholt FP, Hultenby K, Oldberg A, Heinegard D. 1990. Osteopontin-A possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475.
24. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101-1111.
25. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA. 1993. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem 268:9901-9907.
26. Tanaka S, Takahashi T, Takayanagi H, Miyazaki T, Oda H, Nakamura K, Hirai H, Kurokawa T. 1998. Modulation of osteoclast function by adenovirus vector-induced epidermal growth factor receptor. J Bone Miner Res 13:1714-1720.
27. Tani-Ishii N, Tsunoda A, Umemoto T. 1997. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro. J Periodontal Res 32:480-486.
28. Tezuka K, Sato T, Kamioka H, Nijweide PJ, Tanaka K, Matsuo T, Ohta M, Kurihara N, Hakeda Y, Kumegawa M. 1992. Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun 186:911-917.
29. Watanabe T, Kuszynski C, Ino K, Heimann DG, Shepard HM, Yasui Y, Maneval DC, Talmadge JE. 1996. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors. Blood 87:5032-5039.
30. Weber GF, Ashkar S, Glimcher MJ, Cantor H. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
31. Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF. 1995. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J Cell Biochem 57:680-690.
32. Yamate T, Mocharla H, Taguchi Y, Igietseme JU, Manolagas SC, Abe E. 1997. Osteopontin expression by osteoclast and osteoblast progenitors in the marine bone marrow: Demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy. Endocrinology 138:3047-3055.
33. Yoshitake H, Rittling SR, Denhardt DT, Noda M. 1999. Osteopontin- deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156-8160.